HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jiaxin Zhou Selected Research

C-Reactive Protein

1/2021Clinical characteristics and outcome of IgG4-related disease with hypocomplementemia: a prospective cohort study.
3/2017The efficacy of tocilizumab for the treatment of Chinese Takayasu's arteritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jiaxin Zhou Research Topics

Disease

24Neoplasms (Cancer)
01/2022 - 10/2019
10Immunoglobulin G4-Related Disease
01/2022 - 11/2015
7Infections
01/2022 - 03/2017
3Alzheimer Disease (Alzheimer's Disease)
06/2022 - 04/2021
3Lung Neoplasms (Lung Cancer)
08/2021 - 11/2020
3Autoimmune Diseases (Autoimmune Disease)
06/2021 - 10/2019
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 10/2019
3Neutropenia
01/2020 - 03/2017
3Inflammation (Inflammations)
10/2019 - 03/2017
2Hypersensitivity (Allergy)
12/2021 - 03/2017
2Neurocognitive Disorders (Clerambault Syndrome)
01/2021 - 01/2021
2Aplastic Anemia (Anemia, Hypoplastic)
01/2020 - 10/2019
2Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2020 - 10/2019
2Cytopenia
01/2020 - 10/2019
2Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
01/2020 - 10/2019
2Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
01/2020 - 10/2019
2Opportunistic Infections (Opportunistic Infection)
01/2020 - 10/2019
2Pancytopenia
01/2020 - 10/2019
2Pneumonia (Pneumonitis)
01/2020 - 10/2019
1Neuroinflammatory Diseases
06/2022
1Autoimmune Pancreatitis
06/2022
1Atrophy
06/2022
1Substance-Related Disorders (Drug Abuse)
04/2022
1Stomach Neoplasms (Stomach Cancer)
01/2022
1Rheumatoid Arthritis
01/2022
1Carcinogenesis
01/2022
1Foot and Mouth Disease Hand (Hand, Foot, Mouth Disease)
01/2022
1Sialadenitis
12/2021
1Behcet Syndrome (Behcet's Syndrome)
12/2021
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
12/2021
1Rheumatic Diseases (Rheumatism)
12/2021
1Pulmonary Arterial Hypertension
11/2021
1Left Ventricular Dysfunction
11/2021
1Interstitial Lung Diseases (Interstitial Lung Disease)
11/2021
1Systemic Scleroderma (Systemic Sclerosis)
11/2021
1Fibrosis (Cirrhosis)
11/2021
1COVID-19
05/2021
1Cryoglobulinemia
01/2021
1Diffuse Scleroderma (Progressive Systemic Sclerosis)
01/2021
1Lung Injury
11/2020
1Intestinal Polyposis (Polyposis, Intestinal)
09/2020
1Pericardial Effusion
08/2020

Drug/Important Bio-Agent (IBA)

20Immune Checkpoint InhibitorsIBA
01/2022 - 10/2019
6GlucocorticoidsIBA
06/2022 - 11/2015
6Immunoglobulin G (IgG)IBA
06/2022 - 08/2019
4Pharmaceutical PreparationsIBA
01/2022 - 08/2019
4Adrenal Cortex Hormones (Corticosteroids)IBA
01/2020 - 01/2019
3Proteins (Proteins, Gene)FDA Link
06/2022 - 01/2021
3Neutralizing AntibodiesIBA
01/2022 - 05/2021
3Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2021
3LigandsIBA
01/2022 - 01/2020
3Immunosuppressive Agents (Immunosuppressants)IBA
01/2020 - 11/2015
2AutoantibodiesIBA
01/2022 - 06/2021
2Programmed Cell Death 1 ReceptorIBA
01/2022 - 01/2022
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 10/2019
2Monoclonal AntibodiesIBA
01/2022 - 10/2019
2Immunoglobulin A (IgA)IBA
01/2022 - 01/2021
2Biological ProductsIBA
12/2021 - 01/2021
2AntibodiesIBA
05/2021 - 01/2021
2Messenger RNA (mRNA)IBA
01/2021 - 01/2020
2Immunoglobulin E (IgE)IBA
01/2021 - 10/2020
2C-Reactive ProteinIBA
01/2021 - 03/2017
2Complement System Proteins (Complement)IBA
01/2021 - 01/2021
2Inosine Triphosphate (ITP)IBA
01/2020 - 10/2019
2Interleukin-6 (Interleukin 6)IBA
10/2019 - 10/2019
2EnzymesIBA
01/2018 - 03/2017
1SynaptophysinIBA
06/2022
1Adenosine Triphosphate (ATP)IBA
06/2022
1Interleukin-9 (Interleukin 9)IBA
01/2022
1Immunoglobulin M (IgM)IBA
01/2022
1AgarIBA
01/2022
1CarcinogensIBA
01/2022
1nitrosamine 4- (methylnitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA
01/2022
1Azathioprine (Imuran)FDA LinkGeneric
12/2021
1MicroRNAs (MicroRNA)IBA
11/2021
1Uric Acid (Urate)IBA
11/2021
1Triglycerides (Triacylglycerol)IBA
11/2021
1CollagenIBA
11/2021
1Long Noncoding RNAIBA
08/2021
1mRNA VaccinesIBA
05/2021
1Inactivated VaccinesIBA
05/2021
1Protein Isoforms (Isoforms)IBA
04/2021
1Small Interfering RNA (siRNA)IBA
01/2021
1tofacitinibIBA
01/2021
1Cytochromes c (Cytochrome c)IBA
01/2021
1Uridine Diphosphate Glucose (UDP Glucose)IBA
01/2021
1LysophospholipidsIBA
01/2021
1Clemastine (Clemastine Fumarate)FDA LinkGeneric
01/2021
1glyceric acidIBA
01/2021
1Uridine Triphosphate (UTP)IBA
01/2021
1Linoleic Acid (Linoleate)IBA
01/2021
1Uridine Diphosphate (UDP)IBA
01/2021
1Uridine Diphosphate Galactose (UDP Galactose)IBA
01/2021
1CeramidesIBA
01/2021
1Particulate MatterIBA
11/2020

Therapy/Procedure

13Therapeutics
06/2022 - 03/2017
5Immunotherapy
01/2022 - 10/2019
2Aftercare (After-Treatment)
06/2022 - 08/2019
1Anesthesia
01/2021
1Lasers (Laser)
09/2020